New surgical tool for complicated eye surgery

NewsGuard 100/100 Score

Eye surgeons will soon have a new surgical tool to help make a complicated eye surgery less labor intensive while providing significant advantages for corneal transplant patients, as a result of an invention by a Wake Forest University Baptist Medical Center physician.

The new surgical tool, called the EndoSaver Corneal Endothelium Delivery Instrument, is the brainchild of ophthalmologist Keith A. Walter, M.D. Having done hundreds of Descemet's Stripping Endothelial Keratoplasty (DSEK) surgeries, Walter knew he needed a better way of inserting donor endothelial tissue. DSEK is a corneal transplant procedure where surgeons remove only the diseased innermost layer of a host cornea and replace it with healthy cornea tissue from a donor.

"The purpose of the EndoSaver is to make it easier for eye surgeons to insert the living donor tissue without damaging the tissue or crushing the cells," said Walter, an associate professor of ophthalmology at Wake Forest University Eye Center, part of Wake Forest Baptist. "Sparing injury to the fragile button of tissue during this procedure is a key part of patients' quicker visual recovery and provides better long-term results."

Traditionally, eye surgeons use forceps to grasp and fold the donor tissue, insert the tissue into the patient's eye through a 5- to 6-millimeter incision and then unfold the tissue, while attempting to limit damage to the tissue and cells.

With the new device, the donor's tissue layer is rolled up inside itself, similar to a cinnamon roll, and placed inside a spoon-shaped protective sheath. It is then inserted into the patient's eye through a smaller, 4-millimeter incision. "While turning the knob to remove the protective casing, the tissue layer unrolls itself into position as fluid maintains space to accomplish this," said Walter.

Many patients will benefit from use of this device, explained Walter, because the damage to the tissue is limited. It also results in a smaller wound, fewer sutures, fewer problems with post-operative astigmatism, less pain and a quicker visual recovery overall.

To facilitate the design and testing of the surgical device prototype, which is a little larger than a ballpoint pen, Walter worked with staff from the Office of Technology Asset Management at Wake Forest Baptist, which collaborated with Ocular Systems Inc. and Cathtek LLC, companies in the Piedmont Triad Research Park in downtown Winston-Salem, to co-invent the new surgical tool.

"This device demonstrates how quickly an idea can come to market when the inventor, industry partner and university work as a team. It's also very exciting that all the expertise to develop this device is present right here in the Research Park," said Dean Stell, associate director of the Office of Technology Asset Management, which is also located in the Research Park.

The surgical device is currently in clinical trials and has been submitted to the U.S. Food and Drug Administration for approval, which is expected soon. Since the initial idea, it has been a three-year process to develop the EndoSaver. Walter said that similar devices are emerging in the market, but the EndoSaver should be the first one with FDA approval.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Bariatric surgery outperforms traditional treatments for long-term diabetes control